These findings not only suggest an important role for cyclin D1 in colorectal carcinogenesis and progression, but also add support to the accumulating evidence that sex hormones are relevant to the development of CRC, and that prognostic and treatment-predictive molecular biomarkers should be evaluated differently in women and men. This evidence concerns the gene CCND1 and colorectal carcinoma.